A. David McCollum

Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomised Phase 2 study.

L. I. Hecker, A. Spira, A. Cohn, 2013, European journal of cancer.